Pulmonary toxicity and antibiotic resistance risks induced by environmental MRSA exposure in mice

Area of Science:

• Environmental Microbiology
• Pulmonary Toxicology
• Infectious Diseases

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) is prevalent in airborne environments, posing health risks due to its pathogenicity and antibiotic resistance.
• The lungs are susceptible to MRSA infection via the upper respiratory tract, necessitating research into airborne pathogens in specific environments like chicken farms.

Purpose of the Study:

• To investigate the health risks associated with airborne MRSA in chicken farm environments.
• To evaluate the effects of antibiotic interventions on MRSA-induced pulmonary issues.
• To elucidate the mechanisms of MRSA-induced pulmonary inflammation and the efficacy of different antibiotics.

Main Methods:

• In vitro studies using BEAS-2B cells to assess MRSA's impact on cell viability, invasion, adhesion, and barrier function.
• In vivo studies utilizing a mouse infection model to compare short-term treatments with penicillin (resistant) and vancomycin (sensitive).
• Analysis of inflammatory indicators and sequencing data to understand the IL-17 pathway activation and gene expression changes.

Main Results:

• MRSA was found to activate the IL-17 pathway, leading to acute pulmonary inflammation.
• Penicillin treatment increased pathogenic bacteria in the lungs, whereas vancomycin reduced MRSA load.
• Vancomycin effectively downregulated IL-17 pathway gene expression and alleviated inflammation compared to penicillin.

Conclusions:

• Environmentally derived MRSA exhibits acute pulmonary toxicity.
• Antibiotic resistance significantly impacts the short-term treatment efficacy against MRSA-induced lung inflammation.
• Vancomycin demonstrates superior efficacy over penicillin in managing MRSA pulmonary infections, offering insights into treatment strategies.